• 8:26 am » मॉनसून सत्रः दर्शक दीर्घा और चैंबर में भी बैठेंगे माननीय, ये है तैयारी
  • 8:26 pm » दिल्ली: LNJP अस्पताल में 800 सीसीटीवी कैमरे इंस्टॉल, कोरोना मरीजों की हो रही लाइव मॉनिटरिंग
  • 8:26 am » Coronavirus Latest Updates: भारत में 24 घंटे में कोरोना के 57,982 नए केस, अब तक 50,921 मौतें
  • 8:26 pm » कोरोना संकट की वापसी के बीच न्यूजीलैंड में अक्टूबर तक टला आम चुनाव
  • 8:26 am » कोरोना: देश में अब तक 50 हजार मौतें, पिछले 11 दिन में करीब 10 हजार लोगों की गई जान

Geneva: Countries may see a “second peak” of coronavirus circumstances through the first wave of the pandemic if lockdown restrictions have been lifted too quickly, the World Health Organization (WHO) has warned.

Mike Ryan, the WHO’s head of emergencies, instructed a briefing on Monday that the world was “right in the middle of the first wave”, the BBC reported.

He stated as a result of the illness was “still on the way up”, international locations have to be conscious that “the disease can jump up at any time”.

“We cannot make assumptions that just because the disease is on the way down now that it’s going to keep going down,” Ryan stated.

There could be a quantity of months to organize for a second peak, he added.

The stark warning comes as international locations all over the world begin to regularly ease lockdown restrictions, permitting retailers to reopen and bigger teams of folks to assemble.

Experts have stated that and not using a vaccine to present folks immunity, infections may enhance once more when social-distancing measures are relaxed.

Ryan stated international locations the place circumstances are declining ought to be utilizing this time to develop efficient trace-and-test regimes to “ensure that we continue on a downwards trajectory and we don’t have an immediate second peak”.

Also on Monday, Tedros Adhanom Ghebreyesus, WHO Director-General, stated {that a} medical trial of hydroxychloroquine (HCQ) on COVID-19 sufferers has come to “a temporary pause”, whereas the protection knowledge of the the anti-malaria drug was being reviewed.

According to the WHO chief, The Lancet medical journal on May 22 had printed an observational examine on HCQ and chloroquine and its results on COVID-19 sufferers which were hospitalized, reviews Xinhua information company.

The authors of the examine reported that amongst sufferers receiving the drug, when used alone or with a macrolide, they estimated a better mortality price.

“The Executive Group of the Solidarity Trial, representing 10 of the participating countries, met on Saturday (May 23) and has agreed to review a comprehensive analysis and critical appraisal of all evidence available globally,” Tedros stated in a digital press convention.

The developments come as the overall quantity of international COVID-19 circumstances has elevated to five,508,904, with 346,508 deaths, in line with the Johns Hopkins University.